Also demonstrated to be ectopically expressed in several other cancer types, strong evidence abounds implicating CD47 in the pathogenesis and progression of malignancies by its inherent ability to inhibit the phagocytosis of transformed or malignant cells [23,24,25]. This evidence concerns the gene CD47 and cancer.